{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Nuvectis Pharma, Inc. technically bullish or bearish?
As of June 17, 2025, the trend is mildly bullish, supported by daily moving averages, despite some caution from weekly MACD and KST indicators.
What does Nuvectis Pharma, Inc. do?
Nuvectis Pharma, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $5 million and a market cap of $169.45 million. Key financial metrics include a negative P/E ratio, no dividend yield, and a return on equity of -96.22%.
How big is Nuvectis Pharma, Inc.?
As of Jun 18, Nuvectis Pharma, Inc. has a market capitalization of 169.45 million, with net sales of 0.00 million and a net profit of -20.16 million over the last four quarters. The company reported shareholder's funds of 9.71 million and total assets of 18.61 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
